MedTech
Innovation in MedTech is helping to cure, treat and monitor cancer patients faster and more efficiently.
We're supporting the commercialisation of new technologies originating from Cancer Research UK funded research and developing partnerships with industry to accelerate the translation of novel devices and diagnostics from the lab to the clinic.
Collaboration opportunities
Our researchers are developing diagnostics, imaging technologies, medical devices and computational tools, ultimately to drive patient benefit, for which we are seeking licensing and co-development partners.
These partnerships could operate through a variety of models:
Workshops
- Research Innovation sandpits - multi-day workshops to develop multi-disciplinary solutions to real world problems
- Workshops with our researchers to develop collaborative research projects
Research partnerships focussed on our scientific infrastructure
- RadNet - our radiation research network
- ACED - International Alliance for Early Detection
- NCITA – the National Cancer Imaging Translational Accelerator
If you'd like to hear more, or explore an opportunity, get in touch with our team below.
Licensing opportunities
We hold the rights to a wide variety of oncology-focused projects available for licensing or collaboration, including novel chemotherapeutic and biological agents, diagnostic methodologies and enabling technologies.
Cancer Tech Accelerator
We have established the Cancer Tech Accelerator in partnership with Capital Enterprise, MRC and Roche UK to support entrepreneurs develop their tech-enabled concepts into start up companies.
Opening in spring 2022
Interested in a collaboration? Get in touch with our team
